About Dr. Miles

Specialist in Urologic Oncology with additional interest in treatment of enlarged prostate and kidney stones
View Complete CV (resume)

Education

B.S.E., Michigan State University
M.S.E., University of Michigan
M.D., University of Michigan
Surgical Internship, Georgetown University, Washington, DC
Residency in Urology, Walter Reed Army Medical Center, Washington, DC
Board Certified

Awards and Activities

Listed in “America’s Top Doctors for Cancer,” 2005  – Present
Listed in “America’s Top Doctors,” each year 2000 – Present
Listed in “Best Doctors in America,” each year 2002-2006
Listed as a Texas Super Doctor ” in Texas Monthly Magazine 2005 – 2008
Medical Director, Robotic Surgery, The Methodist Hospital 2008 – Present
2010 “Top Prostate Cancer Specialist”, New York Times

Clinical Interests

Urologic oncology, especially prostate cancer, robotic-assisted laparoscopic prostatectomy for cancer, urinary tract reconstruction, and general urology
Research Interests

Prostate cancer patterns of care and outcomes analysis. Development of a means of measuring “Quality of Life” in prostate cancer patients. Gene and vaccine therapy for prostate cancer. Detection of prostate cancer.
Selected Publications

Yang G Addai J, Wheeler TM, Frolov A, Miles BJ, Kadmon D, Thompson TC: Correlative evidence that prostate cancer cell-derived caveolin-1 mediates angiogenesis. Hum Pathol 38(11):688-695, 2007.

Yanagisawa N, Li R, Rowley D, Hao L, Kadmon D, Miles BJ, Wheeler TM, Ayala G: Stromogenic prostatic carcinoma pattern (carcinomas with reactive stromal grade 3) in needle biopsies predict biochemical recurrence-free survival in patients after radical prostatectomy. Hum Pathol 38: 1611-1620, 2007.

Teh BS, Bastasch MD, Mai WY, Kadmon D, Miles BJ, Butler EB: Preliminary report of the effect of high-dose adjuvant intensity modulated radiation therapy on the sural nerve graft for cavernosal nerve sacrifice after radical prostatectomy. Am J Clin Oncol 30:395-400, 2007.

Timme TL, Fujita T, Wang H, Naruishi K, Kadmon D, Amato RJ, Miles BJ, Ayala G, Wheeler TM, Teh BS, Butler EB, Thompson TC: Cytokine gene therapy for genitourinary cancer. Chapter 14 In: Cancer Drug Discovery and Development: Gene Therapy for Cancer. Edited by Hunt KK, Vorburger S. Swisher SG, Totawa NJ: Humana Press, Inc, 2007, pp223-241.

Tetzlaff MT, Teh BS, Timme TL, Fujita T, Satoh T, Tababta K, Mai WY, Vlachaki MT, Amato RJ, Kadmon D, Miles BJ, Ayala G, Wheeler TM, Aguilar-Cordova E, Thompson TC, Butler EB: Expanding the therapeutic index of radiation therapy by combining in situ gene therapy in the treatment of prostate cancer. Technol cancer Res treat 5:23-26, 2006.

Tahir SA, Frolov A, Hayes TG, Mims MP, Miles BJ, Lerner SP, Wheeler TM, Ayala G, Thompson TC, Kadmon D: Preoperative serum caveolin-1 as a prognostic marker for recurrence in a radical prostatectomy cohort. Clin Cancer Res 12:4872-4875, 2006.

Saichi AL, Lee JJ, Taylor RJ, Thompson IM, Miles BJ, Tangen CM, Minasian LM, Pisters LL, Caton JR, Basler JW, Lerner SP, Menter DG, Marshall JR, Crawford ED, Lippman SM: Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of I-selenomethionine: A Southwest Oncology group Study. Clin Cancer Res 12:2178-2184, 2006.

Kattan MW, Miles BJ: Decision making for clinically localized prostate cancer. In: Atlas of the Prostate. Edited by PT Scardino, KM Slawin, Philadelphia: Current Medicine LLC, 2006, pp 137-144.

Ayala G, Satoh T, Li R, Shalev M, Gdor Y, Aguilar-Cordova E, Frolov A, Wheeler TM, Miles BJ, Rauen K, Teh BS, Butler EB, Thompson TC, Kadmon D: Biological response determinants in HSV-tk + ganciclovir gener therapy for prostate cancer. Molecular Therapy 13:716-728, 2006.